You may have heard about Lipoprotein (a), Lp(a) or often referred to as “Lp little a.” Lp(a) is an independent risk factor for cardiovascular disease.The level of Lp(a) found in a person’s blood is entirely genetically predetermined. This means that unlike other cardiac risk factors, Lp(a) can’t … Read More
FH Foundation, World Heart Federation, and International Coalition Collaborate to Tackle the Global Burden of Familial Hypercholesterolemia
The FH Foundation and the World Heart Federation announced today a Global Call to Action on familial hypercholesterolemia (FH), a vastly under-recognized and … Read More
We are excited to announce this new collaboration with Geisinger! We have enclosed the press release below and look forward to updating you on our progress.
Researchers at Geisinger have received $2.8 million from the National Heart, Lung, and Blood Institute of the National Institutes of Health to … Read More
The FH Foundation is a true partnership of individuals and families impacted by FH, and the healthcare professionals who diagnose and treat FH. Together, we are raising awareness of FH, driving improved diagnosis, making sure individuals know their treatment options and opportunities for clinical … Read More
FIND FH® Makes Identifying and Diagnosing Individuals at Genetic Risk for Early Heart Attacks and Stroke Possible
FH Foundation Study Published Online in The Lancet Digital Health and Presented at FH Global Summit
On October 21, 2019 the FH Foundation announced that a … Read More
Familial Hypercholesterolemia Global Impact
In 1998, the World Health Organization (WHO) and several members of the international FH Community published the WHO Report on Familial Hypercholesterolemia (FH). This prescient document included 11 recommendations to address the large gaps in diagnosis and … Read More
Florida State Governor and Miami Dade County Issued Proclamations in Recognition of September 24 as FH Awareness Day
MIAMI (September 26, 2019) – More than 100 VIPS gathered to acknowledge Familial hypercholesterolemia (FH) day on September 24th at the St. Regis Bal Harbour Resort for a panel … Read More
Individuals with familial hypercholesterolemia (FH) were able to lower their cholesterol under FH specialty care, but many are still not meeting LDL-cholesterol targets, according to the FH Foundation’s CASCADE FH® Registry. In new research published in the October issue of Atherosclerosis, 52 … Read More
Researchers at the Mayo Clinic wanted to know if Twitter could help build awareness of familial hypercholesterolemia (FH). The answer was an emphatic yes. In their article published in leading cardiovascular journal, Circulation: Genomic and Precision Medicine, the team compared activity on social … Read More
New research from the FH Foundation highlights that individuals at high risk for cardiovascular events, including those with familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD), experienced more heart attacks, strokes and other cardiovascular events when they were … Read More